Needle-free injector closes first deal:
This article was originally published in Clinica
Executive Summary
Weston Medical has agreed for its needle-free injector technology, Intraject, to be used in Phase III trials of PEGASYS, a compound developed by Swiss company Hoffman La-Roche to treat hepatitis C. This is the first licensing agreement for UK-based Weston's Intraject drug delivery system.